Public Sector Pension Investment Board Halozyme Therapeutics, Inc. Transaction History

Public Sector Pension Investment Board

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$13.33 - $18.66 $1.07 Million - $1.5 Million	-80,300 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$16.68 - $18.41 $241,860 - $266,945	14,500 Added 22.04%	80,300 $1.46 Million
Q1 2018 May 10, 2018	BUY	$17.06 - $21.2 $562,980 - $699,600	33,000 Added 100.61%	65,800 $1.29 Million
Q4 2017 Feb 02, 2018	BUY	$16.75 - $20.8 $549,400 - $682,240	32,800	32,800 $665,000

542

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.35B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Public Sector Pension Investment Board, based on Form 13F filings with the SEC.

Stay updated on Public Sector Pension Investment Board with notifications on news.